Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate
Por um escritor misterioso
Descrição
1-(p-Tolyl)-3-tert-butyl-5-(3-phenylureido)-1H-pyrazole
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead
Molecules, Free Full-Text
Frontiers Urea-based anticancer agents. Exploring 100-years of
Development of an online p38α mitogen-activated protein kinase
Evaluation of Substituted Pyrazole-Based Kinase Inhibitors in One
Figure 2 from Switch control pocket inhibitors of p38-MAP kinase
Structure-based design, synthesis and biological evaluation of N
Targeting the RAS/RAF/MAPK pathway for cancer therapy: from
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead
Structure−Activity Relationships of the p38α MAP Kinase Inhibitor
de
por adulto (o preço varia de acordo com o tamanho do grupo)
